<DOC>
	<DOC>NCT02255409</DOC>
	<brief_summary>Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children Previously Vaccinated in Trial V118_05</brief_summary>
	<brief_title>Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1. Male or female subject who has completed their Day 181 clinic visit for nonnaïve subjects or their Day 209 clinic visit for naïve subjects in parent study. 2. Individuals who give written informed consent, who can comply with study procedures, and who are available for followup 1. Individuals recently vaccinated against influenza. 2. Subjects with contraindications to receive influenza vaccine. 3. Please contact the site for additional eligibility criteria.</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>84 Months</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>